Business Context and Reporting Period
This Form 8-K Current Report was filed by Novavax, Inc. on August 10, 2020. The filing relates to a corporate event under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). The company is incorporated in Delaware and its common stock trades on the Nasdaq Global Select Market under the symbol NVAX.
Key Financial Metrics
This filing is a procedural report regarding securities registration and does not contain financial performance data. Consequently, the following metrics are not provided in this document:
- Revenue
- Profit or Net Income
- Cash Flow
- Profit Margins
- Debt Levels
- Liquidity Ratios
Material Changes
The material event reported is the filing of a Prospectus Supplement to an effective shelf registration statement (Form S-3ASR, File No. 333-237094). The purpose of this filing is to register for resale:
- 4,421,766 shares of the Company's Common Stock ($0.01 par value).
- These shares are held by "Selling Stockholders" identified in the Prospectus Supplement.
- The shares include up to 4,388,850 shares issuable upon conversion of 438,885 shares of Series A Convertible Preferred Stock.
- The shares also include 32,916 shares acquired by Selling Stockholders in private placement financing transactions.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors related to the company's operations. The document focuses solely on the legal registration of shares for resale and includes an attached legal opinion from counsel, Ropes & Gray LLP, regarding the legality of the Common Stock being registered.
Investor Verification Checklist
- Verify the identity of the "Selling Stockholders" in the referenced Prospectus Supplement to understand potential dilution or selling pressure.
- Confirm the conversion terms of the Series A Convertible Preferred Stock to assess the impact of the 4,388,850 convertible shares.
- Review the original Form S-3ASR (File No. 333-237094) filed on March 11, 2020, for broader context on the company's capital structure.
- Check subsequent filings for actual financial performance data, as this 8-K contains none.